Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease-Reference-Cited by-同舟云学术

Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease

Published:2011-09 Issue:1-2 Volume:104 Page:129-136
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

van der Beek N.A.M.E.,van Capelle C.I.,van der Velden-van Etten K.I.,Hop W.C.J.,van den Berg B.,Reuser A.J.J.,van Doorn P.A.,van der Ploeg A.T.,Stam H.

Funder

Erasmus MC Revolving Fund

European Union, 7th Framework Programme “Euclyd — a European Consortium for Lysosomal Storage Diseases”

ZonMw

Prinses Beatrix Fonds

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference34 articles.

1. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling;Ausems;Eur. J. Hum. Genet.,1999

2. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease;Martiniuk;Am. J Med. Genet.,1998

3. Prevalence of lysosomal storage disorders;Meikle;JAMA,1999

4. Pompe's disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity;Lin;J. Inherit. Metab. Dis.,1987

5. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease;Kishnani;J. Pediatr.,2006

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy;Molecular Diagnosis & Therapy;2024-08-12

2. Acid α-glucosidase (GAA) activity and glycogen content in muscle biopsy specimens of patients with Pompe disease: A systematic review;Molecular Genetics and Metabolism Reports;2024-06

3. Man who was unable to dive - typical course of Pompe's disease with late onset;Neurologie pro praxi;2024-03-06

4. Clinical and biochemical footprints of inherited metabolic diseases. XIII. Respiratory manifestations;Molecular Genetics and Metabolism;2023-11

5. A Comprehensive Update on Late-Onset Pompe Disease;Biomolecules;2023-08-22